Did you mean
tests

Search results - 2 results

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

comparable to many surrounding countries. These adjusted prevalences can help estimate the cost of reimbursement of DAA s and invite Belgian policy makers to accelerate the scaling up of reimbursement, giving ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

CONCLUSION: This national monitoring study allowed a clear and objective view of the circulating HCV genotypes in Belgium and will help health authorities in the establishment of cost effectiveness ...

QR code

QR code for this page URL